Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
Completed
Northwestern University
1995-09-01
OBJECTIVES:
I. Determine the relationship between genotype variations and clinical phenotype in patients
with congenital nephrogenic diabetes insipidus.
Study of Genotype and Phenotype Expression in Congenital Nephrogenic Diabetes Insipidus
Completed
National Center for Research Resources (NCRR)
1995-09-01
OBJECTIVES:
I. Determine the relationship between genotype variations and clinical phenotype in patients
with congenital nephrogenic diabetes insipidus.
Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
Completed
Northwestern University
1995-12-01
OBJECTIVES: I. Determine whether diverse mutations of the vasopressin-neurophysin II
(AVP-NPII) gene cause autosomal dominant familial neurohypophyseal diabetes insipidus by
directing the production of an abnormal preprohormone.
II. Determine whether the AVP-NPII gene-directed preprohormone accumulates and destroys
magnocellular neurons because it cannot be folded and processed efficiently.
Study of the Pathogenesis and Pathophysiology of Familial Neurohypophyseal Diabetes Insipidus
Completed
National Center for Research Resources (NCRR)
1995-12-01
OBJECTIVES: I. Determine whether diverse mutations of the vasopressin-neurophysin II
(AVP-NPII) gene cause autosomal dominant familial neurohypophyseal diabetes insipidus by
directing the production of an abnormal preprohormone.
II. Determine whether the AVP-NPII gene-directed preprohormone accumulates and destroys
magnocellular neurons because it cannot be folded and processed efficiently.
Study of Novel Types of Familial Diabetes Insipidus
Unknown status
Northwestern University
1995-12-01
OBJECTIVES:
I. Define the phenotype and genotype of previously unrecognized types of familial diabetes
insipidus (FDI) in kindreds with atypical or novel forms of FDI.
Study of Novel Types of Familial Diabetes Insipidus
Unknown status
National Center for Research Resources (NCRR)
1995-12-01
OBJECTIVES:
I. Define the phenotype and genotype of previously unrecognized types of familial diabetes
insipidus (FDI) in kindreds with atypical or novel forms of FDI.
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.
Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data.
The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free.
thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user.
Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
Alerts Available With Subscription
Alerts are available for users with active subscriptions.
